Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001193125-23-007185
Filing Date
2023-01-12
Accepted
2023-01-12 16:06:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B7 d420468d424b7.htm 424B7 111491
2 GRAPHIC g420468g01a03.jpg GRAPHIC 46805
  Complete submission text file 0001193125-23-007185.txt   177310
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-269059 | Film No.: 23526001
SIC: 2835 In Vitro & In Vivo Diagnostic Substances